MENU
SNSE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sensei Biotherapeutics (SNSE) Ownership - Who owns Sensei Biotherapeutics?
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients... Show more
Profile
Industry
N/A
Address
1405 Research Boulevard
Phone
+1 240 243-8000
Employees
27
Web
https://www.senseibio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.21M
P/E Ratio
N/A
Total Cash
47M
Projected Growth
N/A
Total Debt
4.47M
Revenue
N/A
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash/Share
1.86
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SNSE
Capitalization
10.2M
P/E Ratio
N/A
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash
47M
Total Cash/Share
1.86
Total Debt
4.47M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
45.8M
P/B Ratio
0.27
Cash Flow
N/A
Earnings
-1.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
8.84
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-28.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-44.18
Shares Held By Institutions
1.55M
Shares Outstanding - Current
25.2M
Total Liabilities
7.48M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-17.384
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1405 Research Boulevard
Phone
+1 240 243-8000
Employees
27
Web
https://www.senseibio.com